AIMC Topic: Phosphodiesterase Inhibitors

Clear Filters Showing 1 to 3 of 3 articles

In silico-driven protocol for hit-to-lead optimization: a case study on PDE9A inhibitors.

Journal of computer-aided molecular design
Hit-to-lead (H2L) optimization is a critical stage in small-molecule drug discovery, where efficient exploration of chemical space is required to identify promising lead compounds. Conventional H2L workflows rely on iterative synthesis and experiment...

Immediate post-operative PDE5i therapy improves early erectile function outcomes after robot assisted radical prostatectomy (RARP).

Journal of robotic surgery
To assess whether the timing of post-operative Phosphodiesterase Inhibitor (PDE5i) therapy after Robot-Assisted Radical Prostatectomy (RARP) is associated with a change in early erectile function (EF) outcomes, continence or safety outcomes. Data wer...

Gaussian Process Regression Models for the Prediction of Hydrogen Bond Acceptor Strengths.

Molecular informatics
We present two approaches for the computation of hydrogen bond acceptor strengths, one by machine-learning and one by a composite quantum-mechanical protocol, both based on the well-established pK scale and dataset. The QM calculations after a necess...